NIKA PHARMACEUTICALS, INC
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation
CO
Business Address
2269 MERRIMACK VALLEY AVENUE, HENDERSON, NV, 89044
Mailing Address
2269 MERRIMACK VALLEY AVENUE, HENDERSON, NV, 89044
Phone
7023263615
Fiscal Year End
1231
EIN
900292940
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 25, 2026 | View on SEC |
| 10-Q Quarterly financial report | November 7, 2025 | View on SEC |
| 10-Q Quarterly financial report | August 14, 2025 | View on SEC |
| 10-Q Quarterly financial report | May 13, 2025 | View on SEC |
Annual Reports
10-K
March 25, 2026
- Transitioning from shell entity to health product developer and distributor
- Completed merger with Nika BioTechnology, Inc. to secure 80% of Nika Europe, Ltd.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.